These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23768133)

  • 1. Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.
    Tseng HS; Lin C; Chan SE; Chien SY; Kuo SJ; Chen ST; Chang TW; Chen DR
    World J Surg Oncol; 2013 Jun; 11():139. PubMed ID: 23768133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
    Cao AY; He M; Huang L; Shao ZM; Di GH
    World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
    Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.
    Wu J; Ding S; Lin L; Fei X; Lin C; Andriani L; Goh C; Huang J; Hong J; Gao W; Zhu S; Wang H; Huang O; Chen X; He J; Li Y; Shen K; Chen W; Zhu L
    Cancer Res Treat; 2020 Jul; 52(3):671-679. PubMed ID: 32019280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
    Tan RYC; Ong WS; Lee KH; Park S; Iqbal J; Park YH; Lee JE; Yu JH; Lin CH; Lu YS; Ono M; Ueno T; Naito Y; Onishi T; Lim GH; Tan SM; Lee HB; Koh J; Han W; Im SA; Tan VKM; Phyu N; Wong FY; Tan PH; Yap YS
    J Natl Compr Canc Netw; 2024 May; 22(2D):. PubMed ID: 38744306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
    Gwark SC; Lee HS; Lee Y; Lee SB; Sohn G; Kim J; Chung IY; Ko BS; Kim HJ; Son BH; Ahn JH; Jung KH; Kim SB; Lee HJ; Gong GY; Ahn SH; Lee JW
    Ann Surg Oncol; 2019 Jul; 26(7):2166-2174. PubMed ID: 30977015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.
    Isozaki H; Yamamoto Y; Sakai K; Sho T; Ishihara K; Murakami S; Matsumoto S; Takama T
    Acta Med Okayama; 2020 Apr; 74(2):137-143. PubMed ID: 32341588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and prognosis of mucinous breast carcinoma.
    Zhang M; Teng XD; Guo XX; Zhao JS; Li ZG
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):265-9. PubMed ID: 24305754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.
    Park S; Koo J; Kim JH; Yang WI; Park BW; Lee KS
    J Korean Med Sci; 2010 Mar; 25(3):361-8. PubMed ID: 20191033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
    Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
    BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast.
    Poirier É; Desbiens C; Poirier B; Boudreau D; Jacob S; Lemieux J; Doyle C; Diorio C; Hogue JC; Provencher L
    J Surg Oncol; 2018 May; 117(6):1137-1143. PubMed ID: 29205352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society.
    Kim HS; Yoo TK; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Apr; 180(2):461-470. PubMed ID: 32020434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male breast cancers behave differently in elderly patients.
    Tural D; Selçukbiricik F; Aydoğan F; Beşe N; Yetmen O; Ilvan Ş; Büyükünal E; Serdengeçti S
    Jpn J Clin Oncol; 2013 Jan; 43(1):22-7. PubMed ID: 23159765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.